PharmiWeb1h
First Participants Vaccinated with IAVI’s Ebola Sudan Vaccine Candidate in Uganda Amid Ebola Outbreak
The vaccine candidate is being evaluated in a ring vaccination trial as part of a comprehensive public health response NEW YORK CITY, NY / ACCESS Newswire / February 3, 2025 / The first participants ...
PharmiWeb9h
Cold Chain Technologies and Tower Cold Chain Celebrate Landmark Sustainability Achievements
Cold Chain Technologies (CCT) and Tower Cold Chain, a subsidiary of CCT, have reached important milestones in their ongoing ...
PharmiWeb8h
Since 2021, Moderna has launched 23 clinical trials across 110 UK sites
Moderna, Inc. (NASDAQ:MRNA) has announced updates demonstrating substantial R&D investment and progress in the UK, two years ...
PharmiWeb17h
Double-Digit Tariffs Disrupt U.S. Healthcare Costs and Supply Chain Stability, Industry Leaders Warn in Black Book Poll
New Black Book Research survey reveals industry-wide concerns as tariffs on imports from Mexico, Canada, and China threaten ...
PharmiWeb4h
The Arthritis Foundation Celebrates 25 Years of the California Coast Classic Bike Tour and Launches the Inaugural Carolina Hills Classic
ATLANTA, GA / ACCESS Newswire / February 3, 2025 / For 25 years, the award-winning Arthritis Foundation California Coast Classic Bike Tour has been a cornerstone event for cyclists and arthritis ...
PharmiWeb4h
Exxel Pharma's Innovative Small Molecule, EX937, Rapidly Advancing Toward First-In-Human Study for the Treatment of Refractory Chronic Cough
Refractory chronic cough represents a significant unmet need with no FDA-approved treatment options and $11B total addressable global marketFirst-in-human Phase 1/1b single/multiple dose study in ...
PharmiWeb3h
CHMP recommends subcutaneous RYBREVANT® (amivantamab) for the treatment of patients with advanced EGFR-mutated non-small cell lung cancer
Janssen-Cilag International NV, a Johnson & Johnson company, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended an ...
PharmiWeb4h
DEXIS Reflects on a Year of Innovation and Unveils Exciting Plans for 2025
QUAKERTOWN, PENNSYLVANIA / ACCESS Newswire / February 3, 2025 / DEXIS, an international leader in dental imaging technologies, celebrates the 2024 launch of its DEXIS digital ecosystem along with ...
PharmiWeb3h
New sustainable plant-based membrane works without fossil-fuel materials and toxic solvents
They are used in cleaning our drinking water, treating sewage, processing foods and keeping pharmaceuticals safe – membranes are a crucial part of everyday life. Now, chemical engineers at the ...
PharmiWeb6h
Eckert & Ziegler SE: IT Incident Affects Eckert & Ziegler SE's Communication Channels
MiscellaneousEckert & Ziegler SE: IT Incident Affects Eckert & Ziegler SE's Communication Channels 03.02.2025 / 13:23 CET/CESTThe issuer is solely responsible for the content of this ...
PharmiWeb6h
CTT Pharma Reduces Authorized Share Count
TAMPA, FL / ACCESS Newswire / February 3, 2025 / CTT Pharmaceuticals Holdings, Inc. (OTC:CTTH) is pleased to announce a reduction in its authorized share count by 150 million shares. CTT reduced the ...
PharmiWeb9h
Dedalus Surges Ahead in Europe & Latin America: Black Book Research's Top-Ranked Digital Health Leader
Ranked #1 in EHR & Digital Health Solutions by Black Book Research surveys of nearly 28,000 global EHR users-Leading Innovation Across All Spanish-Speaking Latin American Countries, Germany, Austria, ...